Douglas B Esberg , M.D.

GENERAL

Age: 45      Gender: M
Years in practice: 11
Main Line HealthCare Physician

Medical School:
New York Medical College

Internship:
Columbia Presbyterian Medical

Residency:
Columbia Presbyterian Medical

Fellowship:
Thomas Jefferson University Hospital

Affiliations:

• Bryn Mawr Hospital - On staff since 2001
• Lankenau Medical Center - On staff since 2001
• Paoli Hospital - On staff since 2008
• Riddle Hospital - On staff since 2008

Academic Titles:
Assistant Clinical Professor of Medicine

Clinical/Dept Titles:
Program Director, Fellowship in Clinical Cardiac Electrophysiology

PRACTICE

Practice Name:
MLHC Lankenau Heart Group

Locations:

Lankenau MOB East, Suite 556 100 East Lancaster Avenue Wynnewood, PA  19096 TEL: 610.649.6980 FAX: 610.649.6990

Access Information:  Public Transportation,Handicap Access Hours: Weekdays

7114 Ridge Avenue Philadelphia, PA  19128 TEL: 610.649.6980 FAX: 610.649.6990

Access Information:  Public Transportation,Handicap Access Hours: Weekdays

PUBLICATIONS & CITATIONS

Academic Title

Assistant Clinical Professor of Medicine -

Recent Clinical Studies Published

Clinical Study Participation

• Guidant siteline lead study
  • Sub-investigator
• LV Capture Management Clinical Trial (Medtronic)
  • Site Principle Investigator
• AWARE (St. Jude)
  • Site Principle Investigator
• PEGASUS (Guidant)
  • Site Principle Investigator
• Block HF (Medtronic)
  • Sub-investigator
• Chili VT Study (Boston Scientific)
  • Sub-investigator
• DIARY (Guidant)
  • Sub-investigator
• InSync III Marquis Study (Medtronic)
  • Sub-investigator
• Evaluation of Radiofrequency Ablation of Typical (Type I) Atrial Flutter Using the Navi-Star™ DS (8mm tip) Catheter with the Stockert 70™ RF Generator. (Boston Scientific)
  • Site Principle Investigator
• Freezor™ Trial Of Supraventricular Tachycardia (FROSTY). (Cryocath)
  Evaluation of the 7Fr Freezor Focal Ablation Catheter to treat AVRT, AVNRT and AF
  • Sub-investigator
• Synergistic Effects of Risk Factors for Sudden Cardiac Death (SERF). (Guidant)
  • Site Principle Investigator
• Silent Atrial Fibrillation Detection with Stored Electrograms (SAFE). (Guidant)
  • Sub-investigator
• Atrial High Rate Episodes in Pacemaker Patients (AHIRATE). (Medtronic)
  • Site Principle Investigator
• AutoCapture Capabilities with ICD Leads. (St. Jude)
  • Sub-investigator
• Marquis VR Clinical Study. (Medtronic)
  • Sub-investigator
• A Six-Month Multi-center, Double-blind, Placebo-controlled, Parallel-group design Clinical Study to Assess The Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride for the Treatment of Atrial Fibrillation in Patients Who Require Electrical Cardioversion, with an Open-label Follow-up Phase to Assess the Long-term Efficacy and Safety of 125 mg Daily Oral Dose of Azimilide Dihydrochloride.
  • Sub-investigator
• Placebo-controlled Dose-finding Safety and Tolerability Study of Dofetilide in Patients with an Implantable Cardioverter Defibrillator (ICD).
  • Sub-investigator

Publications

Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, McGuire M, Brown S and Lerew D. Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 2007; 115(1).

Natarajan S, Henthorn R, Burroughs J, Esberg D, Zweibel S, Ross T, Kroll M and Gianola D. "Tuned" Defibrillation Waveforms Outperform 50/50% Tilt Defibrillation Waveforms: A Randomized Multi-Center Study. PACE 2007; vol 30 (Supplement 1): S139-S142.

Esberg D, Kowey P. Does “Anti-lipid” Also Mean "Anti-arrhythmic" [Editorial]. J of Cardiac Failure 2005; 11(9): 693-694.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Cardiac-resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure (COMPANION), NEJM 2004; 350(21): 2140-50.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA. 2002 Dec 25;288(24):3115-23.

Esberg D, Greenspon AJ. Avoiding Complications of Catheter Ablation: A Review of the Current State of the Art [Review]. J Invasive Cardiol 2001; 13(4): 323-327.

Recent Honors, Awards, Citations

Fellowship in Cardiovascular Medicine
Thomas Jefferson University Hospital, Philadelphia, PA
7/97-6/00

Fellowship in Clinical Cardiac Electrophysiology
Thomas Jefferson University Hospital, Philadelphia, PA
7/00-6/01

Current Memberships and Activities

• Fellow - American College of Cardiology
• Fellow - Heart Rhythm Society

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.